Abstract:Human brain organoids are emerging models to study human brain development and pathology as they recapitulate the development and characteristics of major neural cell types, and enable manipulation through an in vitro system. Over the past decade, with the advent of spatial technologies, mass spectrometry imaging (MSI) has become a prominent tool for metabolic microscopy, providing label-free, non-targeted molecular and spatial distribution information of the metabolites within tissue, including lipids. This technology has never been used for studies of brain organoids and here, we set out to develop a standardized protocol for preparation and mass spectrometry imaging of human brain organoids. We present an optimized and validated sample preparation protocol, including sample fixation, optimal embedding solution, homogenous deposition of matrices, data acquisition and processing to maximize the molecular information derived from mass spectrometry imaging. We focus on lipids in organoids, as they play critical roles during cellular and brain development. Using high spatial and mass resolution in positive- and negative-ion modes, we detected 260 lipids in the organoids. Seven of them were uniquely localized within the neurogenic niches or rosettes as confirmed by histology, suggesting their importance for neuroprogenitor proliferation. We observed a particularly striking distribution of ceramide-phosphoethanolamine CerPE 36:1; O2 which was restricted within rosettes and of phosphatidyl-ethanolamine PE 38:3, which was distributed throughout the organoid tissue but not in rosettes. This suggests that ceramide in this particular lipid species might be important for neuroprogenitor biology, while its removal may be important for terminal differentiation of their progeny. Overall, our study establishes the first optimized experimental pipeline and data processing strategy for mass spectrometry imaging of human brain organoids, allowing direct comparison of lipid signal intensities and distributions in these tissues. Further, our data shed new light on the complex processes that govern brain development by identifying specific lipid signatures that may play a role in cell fate trajectories. Mass spectrometry imaging thus has great potential in advancing our understanding of early brain development as well as disease modeling and drug discovery.

Application of Mass Spectrometry Methods to the Analysis of Lipid Composition of the Human Brain

Mass spectrometry imaging as an emerging tool for studying metabolism in human brain organoids

Cell lipotypes localization in brain by mass spectrometry imaging

Optimized high-throughput protocols for comprehensive metabolomic and lipidomic profiling of brain sample

Omics Scale Quantitative Mass Spectrometry Imaging of Lipids in Brain Tissue using a Multi-Class Internal Standard Mixture

Multiplatform lipid analysis of the brain of aging mice by mass spectrometry

Toward Omics-Scale Quantitative Mass Spectrometry Imaging of Lipids in Brain Tissue Using a Multiclass Internal Standard Mixture

A ToF-SIMS Methodology for Analyzing Inter-Tissue Lipid Distribution Variations and Intra-Tissue Multilevel Mass Spectrometry Imaging Within a Single Rat

Quantitative and Carbon Isotope Ratio Analysis of Fatty Acids Isolated from Human Brain Hemispheres

Molecular Imaging of Human Brain Organoids Using Mass Spectrometry

Unsupervised machine learning using an imaging mass spectrometry dataset automatically reassembles grey and white matter

Absolute Quantitative Imaging of Sphingolipids in Brain Tissue by Exhaustive Liquid Microjunction Surface Sampling–liquid Chromatography–mass Spectrometry

Investigation Of Lipid Distributions By Trifluoroacetic Acid-Enhanced Desorption Electrospray Ionization Mass Spectrometry Imaging

Unravelling the brain metabolome: A review of liquid chromatography - mass spectrometry strategies for extracellular brain metabolomics

Porous Graphitic Carbon-Based Imprint Mass Spectrometry Imaging with an Ambient Liquid Extraction Technique for Enhancing Coverage of Glycerolipids and Sphingolipids in Brain Tissue

Examination of Lipid Distributions in Hydrogel-Expanded Mouse Brain Tissue Using Imaging Mass Spectrometry

In-Depth Chemical Analysis of the Brain Extracellular Space Using In Vivo Microdialysis with Liquid Chromatography-Tandem Mass Spectrometry

Large-scale Lipid Analysis with C=C Location and Sn-Position Isomer Resolving Power

Lipid analysis and lipidomics by structurally selective ion mobility-mass spectrometry

Desorption Electrospray Ionization Cyclic Ion Mobility-Mass Spectrometry Imaging for Traumatic Brain Injury Spatial Metabolomics

Profiling Protein–Protein Interactions in the Human Brain by Refined Cofractionation Mass Spectrometry